Trial
NCT00182455
Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
McMaster University
Collaborators
Janssen-Ortho Inc., Canada; Hamilton Health Sciences Corporation
Condition
Social Phobia
Intervention
Topiramate
Why stopped
loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-02